Control group
Participants in the CON group attended the laboratory twice, once at the start of the study and once at the end, to undertake resting and ambulatory cardiovascular measurements, including HR and BP. Following the first testing session, participants were sent home wearing an ambulatory BP cuff for 24 h. After that 24-h period, the participants were required to continue with their normal life and routines for 4-weeks (28 days). At the end of the 4-week period, participants were once again required to attend the laboratory, within a 72-h window, for final resting and ambulatory cardiovascular measurement.